NEW YORK – Sysmex America said on Tuesday that it is adding CellaVision's DC-1 product for automating blood cell differentials to its distribution portfolio for low-volume hematology labs.
The blood cell analyzer received 510(k) clearance from the US Food and Drug Administration last month and is now available in the US and Canada, Sysmex said in a statement. It provides differential counts of white blood cells, characterization of red blood cell morphology, and platelet estimates.
The DC-1 automates the process of performing blood cell differentials in low-volume labs and "provides labs high quality digital imaging for improved efficiency, quality, connectivity, and staff proficiency," Sysmex America COO Andy Hay said.
The system gets rid of most of the manual steps performed by lab technicians during blood cell differentials and standardizes the testing process by automating cell location and pre-classification, Sysmex said. It also provides access to a comprehensive reference library with historical images and comments.